Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session

269P - Neutrophil to lymphocyte ratio in locally advanced rectal cancer and prognosis of mortality in Mexican patients

Date

27 Jun 2024

Session

Poster Display session

Presenters

Stefan Zilli Hernández

Citation

Annals of Oncology (2024) 35 (suppl_1): S106-S118. 10.1016/annonc/annonc1480

Authors

A.W. Saenz Mamani1, M.D.C. Diaz Romero2, M. Ramirez3, J. Cervantes Bojalil4, V. Salais Michaus4, M. Herrera4, S.M. Miyagui Adame4, G. Calderillo Ruiz4, S. Zilli Hernández4, J. Melchor-Ruan4, E. Ruiz4

Author affiliations

  • 1 ISSSTE Hospita Regional de alta especialidad bicentenario de la Independencia, Tultitlán/MX
  • 2 INCAN - Instituto Nacional de Cancerologia, 14080 - Ciudad de Mexico/MX
  • 3 IMSS - Instituto Mexicano del Seguro Social, coacalco/MX
  • 4 INCAN - Instituto Nacional de Cancerologia, Ciudad de Mexico/MX

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 269P

Background

It is well known that inflammation is a hallmark of cancer perse and it is associated with progression, dissemination and worse outcomes in cancer patients. During daily practice Clinicians have few ways to determine the grade of inflammation in a cancer patient, due to basics of physiology we know that a neutrophil to Lymphocyte ratio (NLR) indicate the balance between immune and adaptive responses an it is an excellent indicator of inflammation together. The main objective was to determine an association of mortality and a high NLR (more than 2.5) in patients diagnosed with locally advanced rectal cancer at Instituto Nacional de Cancerlogia (INCan) in Mexico.

Methods

We have search information about patients with diagnosis of locally advanced rectal cancer in medical record. NLR were calculated from complete blood counts in laboratory test at diagnosis, cutoffs values for the NLR were > 2.5 and < 2.5, this cutoff value was reported in previous studies in population from Latinomerica. To analyze data, we used STATA V.14 and SPSS V.25, we have used the Kolmogorov Smirnov test to determine the normality of the variables, posterior to that we have used chi-square to associate the different variables with the mortality, and finally We have used Kaplan Mier test for survival analisis.

Results

From 2016-2021 358 patients were diagnosed with locally advanced rectal cancer. Mean age of diagnosis was 58 years, 48% were women and 52% were men, 8.7% were rectal cancers located in the upper third, 13.4% middle third, 49.7% lower third, upper and middle third 8.4%, middle and lower third 14.8 % and all three thirds 5%. We have found a association between mortality and the next variables: Neutrophils/lymphocytes ratio (NLR) (p 0.005), grade of tumor (p 0.004), pathologic complete response. Patients had a following of 8 years according to Kaplan Meier the survival at 80 months is 82 % for the patients with NLR less than 2.5 and the survival for patients with more than 2.5 is 69% (p 0.003).

Conclusions

Neutrophils/lymphocytic ratio is associated with higher mortality and worse overall survival in patients with locally advanced rectal cancer in Mexico.

Legal entity responsible for the study

M.D.C. Diaz Romero.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.